nuclear phase-out policy
Scope
Date
~
-
Energy
Hanwha’s REC Silicon plant restarts as US-China tension eases
REC Silicon ASA, a US-based polysilicon maker, in which Hanwha Solutions Corp. and its affiliate have a 33% stake, has restarted operations after a ...
Nov 16, 2023 (Gmt+09:00)
-
Energy
Doosan Enerbility secures contract for cask design from KHNP
South Korea's Doosan Enerbility Co. announced on Thursday it secured a contract for dry storage systems of spent nuclear fuel comprehensive design s...
Nov 02, 2023 (Gmt+09:00)
-
Energy
KHNP submits final bid for Czech Republic’s new nuclear power unit
Korea Hydro & Nuclear Power Co. (KHNP) has submitted a final bid to the Czech Republic’s state-run Elektrarna Dukovany II (EDU II) to cons...
Nov 01, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Central bank
BOK chief says inflation may ease more slowly than expected
South Korea’s central bank chief on Thursday said inflationary pressure in Asia’s fourth-largest economy may ease more slowly than earli...
Oct 19, 2023 (Gmt+09:00)
-
Steel
POSCO Group chief: steel desperately needs corporate solidarity
South Korea’s POSCO Group on Tuesday said its Chairman Choi Jeong-woo presided over the regular meeting of the World Steel Association on Su...
Oct 18, 2023 (Gmt+09:00)
-
Energy
KHNP closes in on Romania’s nuclear plant refurbishment project
Korea Hydro and Nuclear Power Co. (KHNP) is eyeing to participate in a project to refurbish Romania-based Cernavoda Nuclear Power Plant’s unit...
Oct 12, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to conduct Phase 3 trials in Thailand for gout treatment
South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...
Sep 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Energy
US court rules in favor of Korea's nuclear reactor exports
A US district court on Monday dismissed Westinghouse Electric Corp.’s lawsuit against South Korean state-run companies to block their nuclear ...
Sep 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Energy
Hyundai E&C, Poland bolster partnerships in nuclear power
Hyundai Engineering & Construction Co., a major affiliate of South Korean automaker Hyundai Motor Co., is boosting its networks in the nuclear p...
Sep 14, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell Bio's treatment shows promise for advanced liver cancer
South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets OK partial approval for phase 3 of biosimilar in Europe
South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Central bank
BOK head says Korea inflation to dip below mid-2% in H2 2024
South Korea’s central bank chief expected consumer inflation to fall below the mid-2% level in the second half of 2024, adding to predictions ...
Aug 22, 2023 (Gmt+09:00)
-
Energy
Daewoo E&C, KAERI to team up for nuclear tech research
South Korea's Daewoo Engineering & Construction Co. (Daewoo E&C) announced on Friday that it signed a research collaboration memorandum of u...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma gets OK for phase 3 clinical trials of URC102 in Taiwan
South Korea's JW Pharmaceutical has won approval from Taiwan's Food and Drug Administration (TFDA) to conduct phase 3 clinical trials for its gout t...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Aug 10, 2023 (Gmt+09:00)
-
Construction & Planning
Heerim wins supervision contract for Vietnam's Long Thanh Airport
South Korea's Heerim Architects & Planners announced on Monday that it has signed a construction-phase supervision and advisory contract for the...
Aug 07, 2023 (Gmt+09:00)
-
Energy
Westinghouse, KHNP seek licensing dispute arbitration
Korea Hydro & Nuclear Power Co. (KHNP) and Westinghouse Electric Corp. have taken their almost one-year dispute over South Korea’s nuclear...
Aug 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Energy
Daewoo E&C, SK Ecoplant to cooperate in nuclear power
South Korea’s Daewoo Engineering & Construction Co. (Daewoo E&C) and SK Ecoplant Co. will jointly take on the domestic and overseas ma...
Jul 27, 2023 (Gmt+09:00)
-
Energy
KHNP develops world's first accident monitoring system for nuclear reactors
Korea Hydro & Nuclear Power (KHNP) announced on Wednesday that it has successfully developed the Technical Specification Operator Support System...
Jul 19, 2023 (Gmt+09:00)
-
Central bank
BOK warns of household lending risk on growth, inequality
South Korea’s central bank warned that household lending in the country has leaped to the world’s third highest and could hurt long-term...
Jul 17, 2023 (Gmt+09:00)
-
Business & Politics
Korea revives nuclear power for its 2024-2038 energy plan
South Korea is slated to bring forward action steps on its power supply plan for the 2024-2038 period, with a possibility to review building more nu...
Jul 11, 2023 (Gmt+09:00)
-
Electric vehicles
Korea tops US eco-friendly car import rankings despite IRA disadvantage
South Korea retained its top spot in exports of eco-friendly vehicles including electric cars to the US in the first quarter despite challenges pose...
Jul 10, 2023 (Gmt+09:00)
Latest News
- 1 Micron set to supply SOCAMM chips to Nvidia ahead of Samsung, SK Hynix
- 2 POSCO Future M breaks with China in cathode supply chain
- 3 GIC resumes Seoul Finance Center sale in potential megadeal
- 4 South Korea’s Lee, China’s Xi agree on closer ties, peace on Korean Peninsula
- 5 Invesco, SK D&D likely to buy co-living building in Seoul